BRAF and adenoma: Cross-sectional reports have also substantially manifested that over-representation of malignancy hallmarks in SPs including BRAF mutation, MLH1 methylation, MUC5AC demethylation, and CIMP proposes possibly higher risks of CRC compared to conventional adenomas (11–13).